IP Library Granted Patent US 11,615,871
Granted Patent B2
US 11,615,871 · App. 17/159,040 · Granted Mar 28, 2023

Patient-specific medication management system

Inventors: Vikas Gupta (Naperville, IL); Stephen J. Bollish (San Diego, CA); Gail Berglund (Carmel, IN); Timothy W. Vanderveen (Poway, CA); Alan Davison (San Diego, CA); Donald Halbert (San Diego, CA); Jesse J. Guerra (San Diego, CA)
Assignee: CAREFUSION 303, INC.
G16H10/60A61M5/142A61M5/1407A61M5/172G16H20/17G16H40/63A61M2005/14208A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,615,871
App. No.
17/159,040
Granted
Mar 28, 2023
Kind
B2
Abstract

Systems for use with a medical device for controlling an infusion device are provided. In one aspect, a system includes an infusion device that is configurable with operating limit parameters for providing medication to a patient, and a limiting system. The limiting system receives laboratory information associated with a patient, compares current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device, determines that administration of the medication by the infusion device should be prevented based on comparing the operating parameters with the operating limit parameters in view of the laboratory information and, responsive to determining that the operation should be prevented, prevents the administration of the medication by the infusion device, and generates a notification indicating that the operating limit parameters require modification.

Claims (68)

1. A system for controlling an infusion device, the system comprising:

an infusion device configurable with operating limit parameters for administrating a medication to a patient;

one or more processors configured to:

receive laboratory information associated with a patient, the laboratory information comprising at least one of a blood coagulation measure, a vitamin level, a platelet count value, a thromboplastin time, or a serum level;

compare current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of the medication to the patient by the infusion device;

determine that administration of the medication by the infusion device should be prevented based on comparing the current operating parameters with the operating limit parameters in view of the laboratory information;

responsive to determining that the operation should be prevented:

prevent the administration of the medication by the infusion device; and

generate a notification regarding modification of the operating limit parameters.

2. The system of claim 1 , wherein the one or more processors are configured to receive the laboratory information with patient-specific information during an administration of the medication by the infusion device.

3. The system of claim 1 , wherein the operating limit parameters comprise a maximum or minimum total amount of the medication to provide to the patient over a period of time.

4. The system of claim 1 , wherein the one or more processors are configured to:

determine to provide the notification, indicating that the operating limit parameters require modification, to the infusion device based on a location of the infusion device or an identity of a caregiver associated with the infusion device; and

provide the notification to the infusion device for display by the infusion device.

5. The system of claim 1 , wherein the laboratory information is received with patient-specific information, wherein the one or more processors are configured to:

receive updated patient-specific information associated with the patient;

perform another comparison of the current operating parameters of the infusion device with the operating limit parameters in view of the updated patient-specific information;

determine that the another comparison is a favorable comparison; and

cause an administration of the medication by the infusion device to be started based on the favorable comparison.

6. The system of claim 1 , wherein the current operating parameters are associated with a mixture of at least two medications to the patient, and the operating limit parameters comprise dosing limits for providing the mixture of the at least two medications to the patient, wherein the one or more processors are further configured to:

evaluate a concentration of the at least two medications; and

determine the dosing limits for the mixture based on the concentration.

7. The system of claim 1 , wherein the one or more processors are configured to:

initiate a modification of operating limit parameters at the infusion device for providing a medication to the patient based on comparing the current operating parameters with the operating limit parameters in view of the laboratory information, wherein the notification indicates the modification was initiated.

8. The system of claim 7 , wherein the one or more processors are configured to:

receive an input from a caregiver to override the modification of the operating limit parameters; and

cause the initiated modification to be overridden based on the input.

9. A method for controlling an infusion device, the method comprising:

receiving, by one or more processors, laboratory information associated with a patient, the laboratory information comprising at least one of a blood coagulation measure, a vitamin level, a platelet count value, a thromboplastin time, or a serum level;

comparing, by the one or more processors, current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of a medication to the patient by the infusion device;

determining, by the one or more processors, that administration of the medication by the infusion device should be prevented based on comparing the current operating parameters with the operating limit parameters in view of the laboratory information;

responsive to determining that the operation should be prevented, by the one or more processors:

preventing the administration of the medication by the infusion device; and

generating a notification regarding modification of the operating limit parameters.

10. The method of claim 9 , the method further comprising:

determining to provide the notification, indicating that the operating limit parameters require modification, to the infusion device based on a location of the infusion device or an identity of a caregiver associated with the infusion device; and

providing the notification to the infusion device for display by the infusion device.

11. The method of claim 9 , wherein the laboratory information is received with patient-specific information, the method further comprising:

receiving patient-specific information during the administration of the medication by the infusion device, the patient-specific information comprising the laboratory information;

receiving updated patient-specific information associated with the patient;

performing another comparison of the current operating parameters of the infusion device with the operating limit parameters in view of the updated patient-specific information;

determining that the another comparison is a favorable comparison; and

causing the administration of the medication to be started based on the favorable comparison.

12. The method of claim 11 , wherein the patient-specific information comprises at least one of a medication ordered for the patient, a time at which the medication is ordered for the patient, a treatment plan for the patient, a medication resistance of the patient, a weight of the patient, a height of the patient, a body surface area of the patient, an age of the patient, a gender of the patient, a genetic makeup of the patient, or an ethnicity of the patient.

13. The method of claim 9 , wherein comparing the current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information comprises comparing a first weight of the patient provided to the infusion device with a second weight of the patient provided to another medical device.

14. The method of claim 9 , wherein the operating limit parameters comprise a maximum or minimum total amount of the medication to provide to the patient over a period of time.

15. The method of claim 9 , wherein the current operating parameters are associated with a mixture of at least two medications to the patient, and the operating limit parameters comprise dosing limits for providing the mixture of the at least two medications to the patient, the method further comprising:

evaluating a concentration of the at least two medications; and

determining the dosing limits for the mixture based on the concentration.

16. The method of claim 9 , the method further comprising:

initiating a modification of operating limit parameters at the infusion device for providing a medication to the patient based on comparing the current operating parameters with the operating limit parameters in view of the laboratory information.

17. The method of claim 16 , the method further comprising:

receiving an input from a caregiver to override the modification of the operating limit parameters; and

causing the initiated modification to be overridden based on the input.

18. A non-transitory machine-readable medium comprising instructions that, when executed by a computing device, cause the computing device to perform operations for controlling an infusion device, comprising:

receiving, by one or more processors, laboratory information associated with a patient, the laboratory information comprising at least one of a blood coagulation measure, a vitamin level, a platelet count value, a thromboplastin time, or a serum level;

comparing, by the one or more processors, current operating parameters of the infusion device with the operating limit parameters in view of the laboratory information for the patient before and during administration of a medication to the patient by the infusion device;

determining, by the one or more processors, that administration of the medication by the infusion device should be prevented based on comparing the current operating parameters with the operating limit parameters in view of the laboratory information;

responsive to determining that the operation should be prevented, by the one or more processors:

preventing the administration of the medication by the infusion device; and

generating a notification regarding modification of the operating limit parameters.

19. The non-transitory machine-readable medium of claim 18 , the operations further comprising:

receiving the laboratory information with patient-specific information during the administration of the medication by the infusion device.

20. The non-transitory machine-readable medium of claim 18 , wherein the laboratory information is received with patient-specific information, the operations further comprising:

receiving updated patient-specific information associated with the patient;

performing another comparison of the current operating parameters of the infusion device with the operating limit parameters in view of the updated patient-specific information;

determining that the another comparison is a favorable comparison; and

causing the administration of the medication to start based on the favorable comparison.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2021
From: GUPTA, VIKAS; BOLLISH, STEPHEN J.; BERGLUND, GAIL; VANDERVEEN, TIMOTHY W.; DAVISON, ALAN; HALBERT, DONALD; GUERRA, JESSE J.
To: CAREFUSION 303, INC.
Reel/Frame 056568/0170 →
Continuity (4)
Continuation 16042987 · Jul 23, 2018
Continuation 14721995 · May 26, 2015
Continuation 13802679 · Mar 13, 2013
Related Publication 20210151146A1 · May 20, 2021
Cited By (2)
US 12,646,351 US 12,646,352